Discover 1stOncology | Awards | Publications | Conferences | Testimonials | Free Demo

User Case: Using 1stOncology to Identify Immuno-Oncology Drugs in Conjunction with Bone Metastasis

1stOncology and OncoBone, a specialist in oncology and bone diseases, recently published a peer reviewed article "Insights into immuno-oncology drug development landscape with focus on bone metastasis" in the journal Frontiers in Immunology (Impact Factor 7.3).

The novelty of this publication is based on 1stOncology, where we were able to identify novel therapies with targets or properties relevant to bone metastasis with promising data obtained during both early-stage and clinical development.

We are very pleased to see that 1stOncology could be such a substantial resource to dramatically improve the identification of immuno-oncology drug development related to bone metastasis and so rapidly provide the necessary data for this timely and very up to date publication.

Read the full paper here.

Citation: Kähkönen TE, Halleen JM, MacRitchie G, Andersson RM and Bernoulli J (2023) Insights into immuno-oncology drug development landscape with focus on bone metastasis. Front. Immunol. 14:1121878. doi: 10.3389/fimmu.2023.1121878
Published: 05 July 2023.

Discover 1stOncology™

Download Our Brochure

The Most Comprehensive Tool Available

Our active surveillance covers everything from traditional chemotherapies to precision medicine in cancer.

Your Conference Year? Covered!

Executive companion reports and online tools to analyze AACR, ASCO, ASH, BIO, ESMO etc.

Invest in Your Career Development

Contribute to your team while furthering your own career development.

Insights You Can Trust

Since 1999, BioSeeker Group have been 100% dedicated and focused on oncology and for 20 years now, we have provided our world-wide client base with the scientific and business insights required for time-saving and accurate analysis of competing drug development and corporate strategies. Get the full picture by tapping into our expertise and this wealth of knowledge found no-where else.

The 1stOncology™ Service Guarantee

Unlimited support for your research from our experienced analysts dedicated to the field of cancer drug development.